Company Profile
Status:Inactive
Industry:Biotechnology, Wholesales Drugs/Sundries
Doing business as:NuSirt Sciences
Site:nusirt.com
Phone:
Description:NuSirt BioPharma is a privately held biopharmaceutical company headquartered in Nashville TN with research labs in Knoxville, TN. NuSirt is focused on the development of novel drugs for the treatment of diabetes and other metabolic disorders including obesity, arteriosclerosis, and hyperlipidemia. NuSirts first product, NS-0100, uses NuSirts platform technology to combined the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is ...
Addresses:Nashville, TN 37203
1600 Division Street Suite 230, Nashville, TN 37203
49 Music Sq W, Nashville, TN 37203
Members (3):E. D. Grindstaff / Chief Executive Officer Andy Patton / VP Finance, inactive Michael B. Zemel / Founder, inactive
Founded:2007
Categories:Health & Diet Products - Retail
Company size:1-10 employees
Former Employees
| Position at NuSirt Sciences Inc | Next job position | |
|---|---|---|
| Andy Patton | VP Finance & StrategyDec 2012 - Jun 2013 |
MedSolutionsDirector Product Management Since Jun 2013 |
| Antje Bruckbauer | ||
| Ashlyn Breaux | In-House CounselSince Jul 2012 |
|
| Brooke Baggett | Staff ScientistJan 2012 - Jun 2013 |
Berg PharmaLaboratory Technician Since Jul 2013 |
| Lauren Olekszyk | Sales and Marketing AssistantSince Feb 2013 |
|
| Michael Stahl | VP Operations and General CounselSince Mar 2012 |
|
| Michael Zemel | Chief Scientific OfficerSince 2007 |
The University of TennesseeProfessor Emeritus Since May 2012 |